Treatment of recalcitrant hypertrophic lichen planus with upadacitinib
Open Access
- 12 March 2025
- journal article
- case report
- Published by Elsevier in JAAD Case Reports
- Vol. 59, 78-80
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Hypertrophic Lichen Planus: An Up-to-Date Review and Differential DiagnosisArchives of Pathology & Laboratory Medicine, 2023
- Oral tofacitinib effectively treating eruptive and hypertrophic cutaneous lichen planusJAAD Case Reports, 2023
- The Use of Janus Kinase Inhibitors for Lichen Planus: An Evidence-Based ReviewJournal of Cutaneous Medicine and Surgery, 2023
- JAK inhibitors in lichen planus: a review of pathogenesis and treatmentsJournal of Dermatological Treatment, 2022
- Ruxolitinib Cream in the Treatment of Cutaneous Lichen Planus: A Prospective, Open-Label StudyJournal of Investigative Dermatology, 2022
- Comparison of baricitinib, upadacitinib, and tofacitinib mediated regulation of cytokine signaling in human leukocyte subpopulationsArthritis Research & Therapy, 2019